Kuchyne na miru

Noteworthy

Sep 16, 2019
Rife M&A activity the life sciences harms competition and reduces choice, both for patients and for modest-sized biopharma firms seeking help with growing pharmacovigilance and regulatory filing requirements, writes Alan White.
Sep 13, 2019
To ensure patients have timely access to expensive new therapies, biopharma companies have to address commercialization challenges with innovative measures.
Sep 08, 2019
Pharmaceutical Executive
By Meghan Oates-Zalesky
Expedited reviews drive new imperative for iteration and quality data that enable agility and results. Meghan Oates-Zalesky reports.
Sep 05, 2019
As part of the Open Payments program expansion, drug and medical device manufacturers will have to report payments and other “transfers of value” to a broader range of health professionals.
Sep 03, 2019
Patients, clinicians, pharmacists and the wider public should be front of mind when evaluating priorities and steps towards Identification of Medicinal Products (IMDP) and other emerging standards, writes Frits Stulp.
Aug 27, 2019
Every big shift will stir up dissenters, but these negative forces can actually offer a useful contribution and could make all the difference in regulatory information management transformation, writes Steve Gens.
Aug 23, 2019
A key question for an organization post-M&A is: “What organizational capabilities support global guidance and leadership, and which require these at the local level?” Scott Hull discusses potential solutions.
Aug 21, 2019
Patient support program providers should incorporate new technologies for more effective processes, but match them with empathy, human connectivity and personalized clinical interventions, writes Tommy Bramley.
Aug 20, 2019
Many real-world data sources contain unstructured text, making it difficult to glean actionable insights from the data. Natural language processing technology can alleviate this problem, writes Jane Z. Reed.
Aug 16, 2019
Ben Jacoby looks at the potential for disruption caused by major changes in medical-device transparency and traceability requirements, and offers a practical response.
native1_300x100
topobzor.info

website development

гранитная плитка цена
lorem ipsum